56
22
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10894 |
CSF1R-IN-1
|
c-Fms | Tyrosine Kinase/Adaptors |
CSF1R-IN-1 是一种 CSF1R 抑制剂 (IC50:0.5 nM)。 | |||
T13194 |
CSF1R-IN-2
|
c-Fms; c-Met/HGFR; Src | Angiogenesis; Tyrosine Kinase/Adaptors |
CSF1R-IN-2 是一种口服具有活力的、有效的 SRC,MET 和 c-FMS 抑制剂,它们的 IC50 值分别为 0.12 nM,0.14 nM 和 0.76 nM。 | |||
T64066 |
CSF1R-IN-3
|
c-Fms; CSF-1R | Tyrosine Kinase/Adaptors |
CSF1R-IN-3是一种口服有效的 CSF-1R 抑制剂,IC50值为2.1nM。CSF1R-IN-3对结直肠癌细胞具有抗增殖活性。CSF1R-IN-3 通过抑制巨噬细胞的迁移,诱导 M2 型巨噬细胞重新编程为 M1 型巨噬细胞,从而表现出抗肿瘤作用和提高免疫力的作用,展现对结直肠癌细胞的活性。 | |||
T62313 |
CSF1R-IN-10
|
Others | Others |
CSF1R-IN-10 (Compound 48) 是一种 CSF-1R 抑制剂 (IC50: 0.005 μM)。 | |||
T61893 |
CSF1R-IN-12
|
Others | Others |
CSF1R-IN-12 是一种有效的集落刺激因子1受体 CSF1R 抑制剂。CSF1R-IN-12 在癌症疾病中具有研究潜力。 | |||
T62190 |
CSF1R-IN-7
|
Others | Others |
CSF1R-IN-7 (Formula I) 是一种 CSF-1R 抑制剂,能够用于研究阿尔兹海默症。 | |||
T62364 |
CSF1R-IN-5
|
Others | Others |
CSF1R-IN-5 是一种 CSF1R 的有效抑制剂。其中 CSF-1R 表达于巨噬细胞中,巨噬细胞的存活和分化依赖于 CSF-1/CSF-1R 信号通路。CSF1R-IN-5 可以影响 TAM 和胶质瘤细胞之间炎症因子的交换。CSF1R-IN-5 具有潜力进行癌症疾病的研究。 | |||
T62318 |
CSF1R-IN-9
|
Others | Others |
CSF1R-IN-9 (Compound 46) 是一种 CSF-1R 抑制剂 (IC50: 0.028 μM)。 | |||
T79472 |
CSF1R-IN-17
|
c-Fms | Tyrosine Kinase/Adaptors |
CSF1R-IN-17(compound 9)是一种选择性高的CSF1R拮抗剂,表现出0.2 nM的低IC50值,并能有效抑制破骨细胞的分化。 | |||
T62390 |
CSF1R-IN-8
|
Others | Others |
CSF1R-IN-8 (Compound 22) 是一种 CSF-1R 抑制剂 (IC50: 0.012 μM)。 | |||
T62187 |
CSF1R-IN-6
|
Others | Others |
CSF1R-IN-6 是一种 CSF1R 的有效抑制剂。其中 CSF-1R 表达于巨噬细胞中,巨噬细胞的存活和分化依赖于 CSF-1/CSF-1R 信号通路。CSF1R-IN-6 能够影响 TAM 和胶质瘤细胞之间炎症因子的交换。CSF1R-IN-6 对癌症疾病表现出潜在的研究价值。 | |||
T61554 |
CSF1R-IN-13
|
Others | Others |
CSF1R-IN-13 is a powerful CSF1R inhibitor with potential applications in researching cancer diseases [1]. CSF1R, also known as colony stimulating factor 1 receptor, is a critical growth factor that regulates various cell types, including bone marrow progenitor cells, monocytes, macrophages, and giants [1]. CSF1R-IN-13 shows promise in furthering our understanding of cancer-related disorders (WO2019134661A1, compound 32) [1]. | |||
T62557 |
CSF1R-IN-14
|
Others | Others |
CSF1R-IN-14 是一种异吲哚啉酮衍生物化合物,是一种 CSF1R 的有效抑制剂。其中集落刺激因子1 (CSF-1,又称巨噬细胞集落刺激因子,M-CSF) 是一种控制骨髓祖细胞、单核细胞、巨噬细胞和巨噬细胞的重要生长因子。CSF1R-IN-14 具有潜力进行癌症疾病的研究。 | |||
T62342 |
CSF1R-IN-4
|
Others | Others |
CSF1R-IN-4 是一种 CSF-1R 的有效抑制剂。其中 CSF-1R 表达于巨噬细胞中,巨噬细胞的存活和分化依赖于 CSF-1/CSF-1R 信号通路。CSF1R-IN-4 能够影响 TAM 和胶质瘤细胞之间炎症因子的交换。CSF1R-IN-4 具有潜力进行癌症疾病的研究。 | |||
T72574 |
Axl/Mer/CSF1R-IN-1
|
Others | Others |
Axl/Mer-IN-1 是一种 Axl/Mer 受体酪氨酸激酶 (Axl/Mer RTK) 和CSF1R 抑制剂,Kd 值均小于 0.1 μM。 | |||
T6119 |
Sotuletinib
BLZ945 |
c-Fms; CSF-1R | Tyrosine Kinase/Adaptors |
Sotuletinib (BLZ945) 是一种选择性的、有效的、脑渗透性的CSF-1R (c-Fms)抑制剂 (IC50:1 nM),选择性是其他受体酪氨酸激酶同系物的 1000 倍。 | |||
T14380 |
AZD7507
|
CSF-1R; HER; Sodium Channel | Angiogenesis; JAK/STAT signaling; Membrane transporter/Ion channel; Tyrosine Kinase/Adaptors |
AZD7507 是口服具有活力的CSF-1R 抑制剂,具有抗肿瘤作用。 | |||
T5586 |
cFMS Receptor Inhibitor II
|
c-Fms | Tyrosine Kinase/Adaptors |
cFMS Receptor Inhibitor II 是 CSF-1R 激酶抑制剂。其中 CSF-1 是细胞因子。 | |||
TQ0015 |
PRN1371
|
c-Fms; FGFR; CSF-1R | Angiogenesis; Tyrosine Kinase/Adaptors |
PRN1371 是一种高效的、选择性的FGFR1-4和CSF1R 抑制剂,对FGFR1,FGFR2,FGFR3,FGFR4 和 CSF1R 的IC50值分别为 0.6,1.3,4.1,19.3 和 8.1 nM。 | |||
T7100 |
PLX5622
PLX-5622 |
c-Fms; CSF-1R | Tyrosine Kinase/Adaptors |
PLX5622 是一种选择性的、高效的、能透过血脑屏障的、口服具有活性的 CSF1R 抑制剂 (IC50= 0.016 µM;Ki= 5.9 nM),具有较好的药理学特性,可用于病程发展前和过程中,扩大的和特异性的小胶质细胞的消除。 | |||
T2659 |
GW2580
GW 2580,SC-203877 |
c-Fms | Tyrosine Kinase/Adaptors |
GW2580 (SC-203877) 是一种口服有效的、选择性的 c-Fms 激酶抑制剂,体外实验中在 0.06 μM 时可完全抑制人 cFMS 激酶。它是 ATP 与 cFMS 激酶结合的竞争性抑制剂,能够抑制集落刺激因子 1 信号传导。 | |||
T10652 |
Vimseltinib
DCC-3014 |
c-Fms; CSF-1R; c-Kit | Tyrosine Kinase/Adaptors |
Vimseltinib (DCC-3014) 是 c-FMS(CSF-IR) 和 c-Kit 抑制剂,IC50值分别为 <0.01 μM 和 0.1-1 μM。 | |||
T2115 |
Pexidartinib
PLX-3397 |
Apoptosis; c-Fms; FLT; CSF-1R; c-Kit | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
Pexidartinib (PLX-3397) 是一种 CSF-1R 和 c-Kit 的抑制剂 (IC50=20/10 nM),具有选择性、ATP 竞争性和口服活性。Pexidartinib 具有抗肿瘤活性,可以诱导细胞凋亡。 | |||
T2624 |
OSI-930
OSI 930,噻尔非尼 |
Apoptosis; c-Fms; Raf; VEGFR; FLT; CSF-1R; Src; c-Kit | Angiogenesis; Apoptosis; MAPK; Tyrosine Kinase/Adaptors |
OSI-930 是 Kit,KDR 和 CSF-1R (c-Fms)的口服选择性抑制剂,IC50分别为 80 nM,9 nM 和 15 nM。它具有抗肿瘤活性,靶向肿瘤中的癌细胞增殖和血管生成。它还适度抑制 Flt-1,c-Raf 和 Lck,并且对 PDGFRα/β,Flt-3和 Abl 具有较弱的抑制活性。 | |||
T35570 |
Chiauranib
CS2164,西奥罗尼 |
c-Fms; VEGFR; FLT; PDGFR; c-Kit; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors |
Chiauranib 是一种针对肿瘤血管生成的多靶点抑制剂,具有强大的抗癌作用。 Chiauranib 有效抑制血管生成相关激酶(VEGFR1、VEGFR2、VEGFR3、PDGFRα 和 c-Kit)、有丝分裂相关激酶 Aurora B 和慢性炎症相关激酶 CSF1R,IC50 值范围为 1-9 nM。 | |||
T15199 |
Edicotinib
JNJ-527,JNJ-40346527 |
c-Fms; FLT; CSF-1R; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Edicotinib (JNJ-527) 是能够透过血脑屏障的、口服具有活性的、选择性的CSF-1R 抑制剂 (IC50:3.2 nM)。它对 KIT (IC50:20 nM) 和 FLT3 (IC50:190 nM) 的抑制作用较小。它抑制小胶质细胞的扩张,减弱小胶质细胞的增殖和神经退行性变。它可用于研究阿尔茨海默病和类风湿性关节炎。 | |||
T4315 |
Ki20227
N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-甲氧基苯基]-N'-[1-(2-噻唑基)乙基]脲 |
c-Fms; VEGFR; CSF-1R; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Ki20227 是一种高效的、口服具有活性的、选择性的CSF1R(c-Fms 酪氨酸激酶)抑制剂,对 CSF1R,VEGFR2,c-Kit 和PDGFRβ的IC50分别为 2 nM,12 nM,451 nM 和 217 nM。它可以阻止破骨细胞分化和溶骨性破坏。 | |||
T6930 |
Pazopanib Hydrochloride
GW786034,Pazopanib HCl,GW786034 HCl,盐酸帕唑帕尼,Votrient HCl,Armala |
c-Fms; VEGFR; FGFR; PDGFR; c-Kit; Autophagy | Angiogenesis; Autophagy; Tyrosine Kinase/Adaptors |
Pazopanib Hydrochloride (Votrient HCl) 是一种多靶点抑制剂,抑制 VEGFR1、VEGFR2、VEGFR3、PDGFRβ、c-Kit、FGFR1和c-Fms 的IC50分别为10、30、47、84、74、140和146 nM。 | |||
T6289 |
Dovitinib
TKI258,多韦替尼,CHIR-258,度维替尼 |
VEGFR; FGFR; FLT; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Dovitinib (CHIR-258) 是一种口服有效的、多靶点的酪氨酸激酶 (RTK) 抑制剂,具有抗肿瘤作用。 | |||
T6028 |
PF 477736
PF 00477736,PF-477736,PF-736,PF-00477736,PF477736 |
c-Fms; VEGFR; FGFR; FLT; c-RET; Chk; CDK; Src; Aurora Kinase | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors |
PF 477736 (PF-736,PF-00477736) 是一种特异性、有效且具有 ATP 竞争性的 Chk1 抑制剂,Ki 值为0.49 nM。它也是Chk2抑制剂,Ki 值为 47 nM。它还抑制VEGFR2、Fms、Yes、Aurora-A、FGFR3、Flt3和Ret。 | |||
T2514 |
Linifanib
利尼伐尼,ABT-869,RG3635,AL-39324 |
Apoptosis; c-Fms; VEGFR; FLT; CSF-1R; PDGFR; c-Kit; Autophagy | Angiogenesis; Apoptosis; Autophagy; Tyrosine Kinase/Adaptors |
Linifanib (AL-39324) 是一种高效口服的VEGFR 和PDGFR 家族多靶点抑制剂,具有显著的抗肿瘤活性。它对无关 RTKs、可溶性酪氨酸激酶或丝氨酸/苏氨酸激酶的活性要低得多。它是特异性 miR-10b 抑制剂,阻断miR-10b 的生物合成。 | |||
T1925 |
PLX647
|
c-Fms; c-Kit | Tyrosine Kinase/Adaptors |
PLX647 是具有口服活性的、高效的、特异性的FMS 和KIT 双激酶抑制剂,IC50分别为 28 和 16 nM。它 (1 μM) 在 400 个激酶组中显示出对 FMS 和 KIT 有选择性,但 FLT3 和 KDR 除外 (IC50=91 和 130 nM)。 | |||
T79157 |
Pimicotinib
ABSK021,ABSK-021 |
c-Fms; Others | Others; Tyrosine Kinase/Adaptors |
Pimicotinib (ABSK021) 为一种有效的 CSF1R 抑制剂,具抗肿瘤活性,可用于研究晚期实体瘤。 | |||
TQ0235 |
AC710
|
FLT; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
AC710是一种 PDGFR 抑制剂,能够作用于 FLT3 (Kd:0.6),CSF1R (Kd:1.57),KIT (Kd:1),PDGFRα (Kd:1.3) 和 PDGFRβ (Kd:1.0)。 | |||
T4075 |
Sulfatinib
KDR-IN-1,索凡替尼 |
VEGFR; FGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Sulfatinib (KDR-IN-1) (HMPL-012) 是一种有效且高度选择性的酪氨酸激酶抑制剂,可抑制VEGFR1/2/3,FGFR1和CSF1R,IC50范围为1 到 24 nM 之间。 | |||
T76776 |
Emactuzumab
RO 5509554,RG 7155 |
c-Fms; TAM Receptor | Tyrosine Kinase/Adaptors |
Emactuzumab(RG 7155) 是一种针对集落刺激因子-1 受体的单克隆抗体,靶向肿瘤相关巨噬细胞 (TAM)。Emactuzumab 具有抗肿瘤活性,可抑制集落刺激因子 1 受体 (CSF1R) 的激活。Emactuzumab 对 CSF-1R 具有高亲和力,Ki 值为 0.2 nM。Emactuzumab 可阻断 CSF-1R 二聚化,可用于研究如弥漫型腱鞘巨细胞瘤(dt-GCT)类的癌症。 | |||
T5172 |
AZ304
|
c-Fms; Raf; p38 MAPK; Autophagy | Autophagy; MAPK; Tyrosine Kinase/Adaptors |
AZ304 是一种 ATP 竞争性双 BRAF 激酶抑制剂,有效抑制 BRAF (WT)、BRAF (V600E) 和野生型 CRAF,IC50值分别为79、38和68 nM。具有抗肿瘤活性。它对 p38 和 CSF1R 也有抑制作用,IC50值分别为 6 nM 和 35 nM。 | |||
T4376 |
Nampt-IN-1
LSN3154567 |
c-Fms; NAMPT; CSF-1R | Metabolism; Tyrosine Kinase/Adaptors |
Nampt-IN-1 (LSN3154567) 是选择性的 NAMPT 抑制剂,能够抑制纯化的 NAMPT,IC50=3.1 nM。 | |||
T35333 |
ARRY-382
|
CSF-1R | Tyrosine Kinase/Adaptors |
ARRY-382 是一种高度选择性的 CSF-1R 口服抑制剂,IC50 为 9 nM。 | |||
T11729 |
JTE-952
|
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
JTE-952 is a oral, potent active and selective Type II inhibitor of colony stimulating factor-1 receptor (CSF-1R or cFMS, type III receptor tyrosine kinase), with IC50 values of 13 nM and 261 nM for CSF1R and TrkA , respectively. Effective against a mouse | |||
T40164 |
BPR1R024
BPR1R024 |
Others | Others |
BPR1R024 is an orally active and selective CSF1R inhibitor ( IC 50 = 0.53 nM). | |||
T10228 |
AC710 Mesylate
|
PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
AC710 Mesylate is a potent PDGFR inhibitor (Kds: 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3, CSF1R, KIT, PDGFRα and PDGFRβ). | |||
T21330 |
JNJ-28312141
JNJ 28312141,JNJ28312141 |
Others | Others |
JNJ-28312141 is an orally active CSF1R inhibitor and a FLT3 inhibitor. JNJ-28312141 is a new agent with potential therapeutic activity in acute myeloid leukemia and in settings where CSF-1-dependent macrophages and osteoclasts contribute to tumor growth a | |||
T29542 |
AC708
AC 708,AC-708 |
Others | Others |
AC708 is a small molecule CSF1R inhibitor that effectively inhibits CSF1R phosphorylation mediated by CSF-1 (IC50 = 26 nM) and IL-34 (IC50 = 33 nM). It also inhibited the activity of growth factor-dependent cells cultured in CSF-1 (IC50 = 38 nM) or IL-34 | |||
T12505 |
PLX5622 hemifumarate
|
c-Fms | Tyrosine Kinase/Adaptors |
PLX5622 hemifumarate 是高度选择性的、能透过血脑屏障的、具有口服活性的 CSF1R 抑制剂,IC50值为 0.016 μM,Ki 值为 5.9 nM,可用于病程发展前和过程中,扩大和特异性的小胶质细胞的消除。PLX5622 hemifumarate 具有较理想的药代动力学特性。 | |||
T69759 |
IACS-9439
|
c-Fms | Tyrosine Kinase/Adaptors |
IACS-9439是一种CSF1R抑制剂,具有高效、选择性和口服活性,Ki值仅为1 nM。适用于研究晚期实体肿瘤。 | |||
T62788 |
Pexidartinib hydrochloride
|
Others | Others |
Pexidartinib hydrochloride (PLX-3397 hydrochloride) 是一种有效的、选择性的、口服具有活力的、ATP-竞争性的集落刺激因子 1 (CSF1R 或 M-CSFR) (IC50: 20 nM) 和 c-Kit (IC50: 10 nM) 抑制剂。Pexidartinib hydrochloride 对 c-Kit 和 CSF1R 的选择性是对其他相关激酶的 10-100 倍,作用于 FLT3 (IC50: 160 nM)、KDR (VEGFR2) (IC50: 350 nM)、LCK (IC50: 860 nM)、FLT1 (VEGFR1) (IC50: 880 nM) 和 NTRK3 (TRKC) (IC50: 890 nM)。Pexidartinib hydrochloride 能够诱导细胞凋亡,表现出抗肿瘤作用。 | |||
T76786 | Cabiralizumab | ||
Cabiralizumab (FPA 008) 是一种抗 CSF1R 单克隆抗体 (MAb)。Cabiralizumab 可增强 T 细胞浸润和抗肿瘤 T 细胞免疫反应。Cabiralizumab 抑制破骨细胞的活化并阻止骨质破坏,可用于类风湿性关节炎 (RA) 的研究。Cabiralizumab 可与 Nivolumab 结合用于肺癌研究。 | |||
T70444 |
Edicotinib HCl
|
Others | Others |
Edicotinib, also known as JNJ-40346527, is a small molecule and orally available inhibitor of colony-stimulating factor-1 receptor (CSF1R; FMS) with potential antineoplastic activity. FMS tyrosine kinase inhibitor JNJ-40346527 blocks the receptor-ligand interaction between FMS and its ligand CSF1, thereby preventing autophosphorylation of FMS. As a result, unphosphorylated FMS cannot activate FMS-mediated signaling pathways, thus potentially inhibiting cell proliferation in FMS-overexpressed tum... | |||
T71400 |
Quizartinib HCl
|
Others | Others |
Quizartinib, also know as AC220 and AC010220, is an orally available FLT3 / STK1 inhibitor with potential antineoplastic activity. Class III receptor tyrosine kinase inhibitor AC220 selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell pro... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-01419 |
CSF1R Protein, Cynomolgus, Recombinant (His)
CSF-1-R,CSF-1 receptor,Proto-oncogene c-Fm... |
Cynomolgus | HEK293 Cells |
Macrophage colony-stimulating factor 1 receptor (CSF1R) is a member of the type III subfamily of receptor tyrosine kinases that also includes receptors for SCF and PDGF. These receptors each contain five immunoglobulin-like domains in their extracellular domain (ECD) and a split kinase domain in their intracellular region. CSF1R is expressed primarily on cells of the monocyte/macrophage lineage, dendritic cells, stem cells and in the developing placenta. CSF1 and its receptor (CSF1R, product of ... | |||
TMPJ-01418 |
CSF1R Protein, Cynomolgus, Recombinant (hFc)
M-CSF-R,CSF1R,CSF-1-R, |
Cynomolgus | HEK293 Cells |
Macrophage colony-stimulating factor 1 receptor (CSF1R) is a member of the type III subfamily of receptor tyrosine kinases that also includes receptors for SCF and PDGF. These receptors each contain five immunoglobulin-like domains in their extracellular domain (ECD) and a split kinase domain in their intracellular region. CSF1R is expressed primarily on cells of the monocyte/macrophage lineage, dendritic cells, stem cells and in the developing placenta. CSF1 and its receptor (CSF1R, product of ... | |||
TMPH-00354 |
CSF1R Protein, Feline, Recombinant (His & SUMO)
FMS,M-CSF-R,CSF-1-R,CSF1R |
Feline | E. coli |
CSF1R Protein, Feline, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 70.8 kDa and the accession number is P13369. | |||
TMPY-01037 |
CSF1R Protein (Met1-Glu512), Human, Recombinant (His)
CSF-1R,CD115,HDLS,FIM2,M-CSF-R,M<... |
Human | HEK293 Cells |
CSF1R Protein (Met1-Glu512), Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 56 kDa and the accession number is P07333-1. | |||
TMPK-00415 |
M-CSFR/CSF1R/CD115 Protein, Human, Recombinant (His & Avi), Biotinylated
CSF-1-R,M-CSF R,C-FMS,FMSFIM2,CSF... |
Human | HEK293 Cells |
M-CSFR/CSF1R/CD115 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 57.4 kDa and the accession number is P07333-1. | |||
TMPK-00656 |
M-CSFR/CSF1R/CD115 Protein, Cynomolgus, Recombinant (His)
M-CSF R,M-CSFR,HDLS,C-FMS,CSF... |
Cynomolgus | HEK293 Cells |
M-CSFR/CSF1R/CD115 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 56.3 kDa and the accession number is G7P8P1. | |||
TMPK-00414 |
M-CSFR/CSF1R/CD115 Protein, Human, Recombinant (His & Avi)
FMSFIM2,FMS,M-CSF R,HDLS,M-CSFR,CSF |
Human | HEK293 Cells |
M-CSFR/CSF1R/CD115 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 57.4 kDa and the accession number is P07333-1. | |||
TMPY-00881 |
CSF1R Protein, Human, Recombinant
FIM2,C-FMS,CD115,CSFR,MCSF Receptor,FMS, |
Human | HEK293 Cells |
CSF1R Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 55.1 kDa and the accession number is P07333-1. | |||
TMPY-05436 |
CSF1R Protein, Mouse, Recombinant (hFc)
AI323359,Csfmr,Fim-2,Fms,colony stimulating factor ... |
Mouse | HEK293 Cells |
CSF1R Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 81.9 kDa and the accession number is P09581. | |||
TMPY-03734 |
CSF1R Protein, Rat, Recombinant (His)
colony stimulating factor 1 receptor |
Rat | HEK293 Cells |
CSF1R Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 56.5 kDa and the accession number is D4ACA7. | |||
TMPY-03920 |
CSF1R Protein, Rat, Recombinant (hFc)
colony stimulating factor 1 receptor |
Rat | HEK293 Cells |
CSF1R Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 82 kDa and the accession number is D4ACA7. | |||
TMPY-05040 |
CSF1R Protein, Rhesus, Recombinant (His)
colony stimulating factor 1 receptor |
Rhesus | HEK293 Cells |
CSF1R Protein, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54.3 kDa and the accession number is XP_001107711.3. | |||
TMPY-05043 |
CSF1R Protein, Rhesus, Recombinant (hFc)
colony stimulating factor 1 receptor |
Rhesus | HEK293 Cells |
CSF1R Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 81.3 kDa and the accession number is XP_001107711.3. | |||
TMPY-01833 |
CSF1R Protein, Mouse, Recombinant (His)
Fim-2,M-CSF-R,CD115,Csfmr,CSF- |
Mouse | HEK293 Cells |
CSF1R Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 56.8 kDa and the accession number is P09581. | |||
TMPY-05429 |
CSF1R Protein, Human, Recombinant (hFc)
FIM2,C-FMS,FMS,MCSF Receptor,CD115,HDLS,CSF |
Human | HEK293 Cells |
CSF1R Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 81.2 kDa and the accession number is P07333-1. | |||
TMPY-05264 |
CSF1R Protein, Human, Recombinant (mFc)
CD115,FIM2,FMS,CSF-1R,colony stimulating f... |
Human | HEK293 Cells |
CSF1R Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 81.5 kDa and the accession number is P07333-1. | |||
TMPY-04938 |
CSF1R Protein, Mouse, Recombinant (His), Biotinylated
CD115,M-CSFR,colony stimulating factor 1 receptor,A... |
Mouse | HEK293 Cells |
CSF1R Protein, Mouse, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 56.8 kDa and the accession number is P09581. | |||
TMPY-04358 |
CSF1R Protein, Human, Recombinant (His & GST)
MCSF Receptor,FMS,colony stimulating factor 1 recep... |
Human | Baculovirus Insect Cells |
CSF1R Protein, Human, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 76 kDa and the accession number is P07333-1. | |||
TMPY-06384 |
CSF1R Protein, Human, Recombinant (His & Avi), Biotinylated
HDLS,FMS,colony stimulating factor 1 receptor,MCSF ... |
Human | HEK293 Cells |
CSF1R Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 57.76 kDa and the accession number is P07333-1. | |||
TMPY-06389 |
CSF1R Protein, Human, Recombinant (hFc & Avi), Biotinylated
FMS,CD115,FIM2,MCSF Receptor,colony stimulating fac... |
Human | HEK293 Cells |
CSF1R Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 83.04 kDa and the accession number is P07333-1. | |||
TMPY-05513 |
CSF1R Protein (Ala299-Glu512), Human, Recombinant (His)
M-CSF-R,HDLS,C-FMS,CSFR,CSF-1... |
Human | HEK293 Cells |
CSF1R Protein (Ala299-Glu512), Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25.3 kDa and the accession number is P07333-1. | |||
TMPY-05045 |
CSF1R Protein, Human, Recombinant (Domain I&II&III, His)
M-CSF-R,colony stimulating factor 1 receptor,HDLS,C... |
Human | HEK293 Cells |
CSF1R Protein, Human, Recombinant (Domain I&II&III, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.1 kDa and the accession number is P07333-1. |